Terms: = Liver cancer AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610
51 results:
1. Risk factors for massive gastrointestinal bleeding occurrence and mortality: A prospective single-center study.
Redondo-Cerezo E; Tendero-Peinado C; López-Tobaruela JM; Fernandez-García R; Lancho A; Ortega-Suazo EJ; López-Vico M; Martínez-Cara JG; Jiménez-Rosales R
Am J Med Sci; 2024 Apr; 367(4):259-267. PubMed ID: 38278359
[TBL] [Abstract] [Full Text] [Related]
2. Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis.
Torun BC; Glehen O; Kepenekian V; Sardi A; Arjona-Sanchez A; Yonemura Y; Barat S; Morris D; Spiliotis J; Coccolini F; Sommariva A; Bartos A; Raza S; Speteen KV; Akin L; Irez T; Canbay E;
Eur J Surg Oncol; 2023 Aug; 49(8):1489-1494. PubMed ID: 37085403
[TBL] [Abstract] [Full Text] [Related]
3. Challenges in the Diagnosis of Epstein-Barr Virus-positive Inflammatory Follicular Dendritic Cell Sarcoma: Extremely Wide Morphologic Spectrum and Immunophenotype.
Li Y; Yang X; Tao L; Zeng W; Zuo M; Li S; Wu L; Lin Y; Zhang Z; Yun J; Huang Y
Am J Surg Pathol; 2023 Apr; 47(4):476-489. PubMed ID: 36574358
[TBL] [Abstract] [Full Text] [Related]
4. Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.
Baldini C; Danlos FX; Varga A; Texier M; Halse H; Mouraud S; Cassard L; Champiat S; Signolle N; Vuagnat P; Martin-Romano P; Michot JM; Bahleda R; Gazzah A; Boselli L; Bredel D; Grivel J; Mohamed-Djalim C; Escriou G; Grynszpan L; Bigorgne A; Rafie S; Abbassi A; Ribrag V; Postel-Vinay S; Hollebecque A; Susini S; Farhane S; Lacroix L; Parpaleix A; Laghouati S; Zitvogel L; Adam J; Chaput N; Soria JC; Massard C; Marabelle A
J Exp Clin Cancer Res; 2022 Jul; 41(1):217. PubMed ID: 35794623
[TBL] [Abstract] [Full Text] [Related]
5. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
[TBL] [Abstract] [Full Text] [Related]
6. CCDC88A/GIV promotes HBV replication and progeny secretion via enhancing endosomal trafficking and blocking autophagic degradation.
Wang X; Wei Z; Lan T; He Y; Cheng B; Li R; Chen H; Li F; Liu G; Jiang B; Lin Y; Lu M; Meng Z
Autophagy; 2022 Feb; 18(2):357-374. PubMed ID: 34190023
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNAs differential expression profile in metastatic colorectal cancer: A pilot study with literature review.
Francone E; Gentilli S; Santori G; Stabilini C; Fornaro R; Frascio M
Surg Oncol; 2021 Jun; 37():101524. PubMed ID: 33556883
[TBL] [Abstract] [Full Text] [Related]
8. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo.
Yin L; Keeler GD; Zhang Y; Hoffman BE; Ling C; Qing K; Srivastava A
Gene Ther; 2021 Aug; 28(7-8):422-434. PubMed ID: 32152434
[TBL] [Abstract] [Full Text] [Related]
9. Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium.
Wan Z; Zhao L; Lu F; Gao X; Dong Y; Zhao Y; Wei M; Yang G; Xing C; Liu L
Theranostics; 2020; 10(1):218-230. PubMed ID: 31903116
[No Abstract] [Full Text] [Related]
10. Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer.
Caballero-Díaz D; Bertran E; Peñuelas-Haro I; Moreno-Càceres J; Malfettone A; López-Luque J; Addante A; Herrera B; Sánchez A; Alay A; Solé X; Serrano T; Ramos E; Fabregat I
J Hepatol; 2020 Jan; 72(1):125-134. PubMed ID: 31562907
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma.
Liao SH; Su TH; Jeng YM; Liang PC; Chen DS; Chen CH; Kao JH
Hepatology; 2019 Jan; 69(1):209-221. PubMed ID: 30014620
[TBL] [Abstract] [Full Text] [Related]
12. Specific issues concerning the management of patients on the waiting list and after liver transplantation.
Burra P; Giannini EG; Caraceni P; Ginanni Corradini S; Rendina M; Volpes R; Toniutto P
Liver Int; 2018 Aug; 38(8):1338-1362. PubMed ID: 29637743
[TBL] [Abstract] [Full Text] [Related]
13. [Retrospective analysis of diagnosis and treatment of breast cancer in pregnancy].
Wang FW; Fu SM; Jin YC; Gong XH; Cheng HD; Wu KJ
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):114-118. PubMed ID: 29397624
[No Abstract] [Full Text] [Related]
14. Is Emergency Transcatheter Hepatic Arterial Embolization Suitable for Spontaneously Ruptured Hepatocellular Carcinoma in Child-Pugh C Cirrhosis?
Fan WZ; Zhang YQ; Yao W; Wang Y; Tan GS; Huang YH; Yang JY; Li JP
J Vasc Interv Radiol; 2018 Mar; 29(3):404-412.e3. PubMed ID: 29249595
[TBL] [Abstract] [Full Text] [Related]
15. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
[TBL] [Abstract] [Full Text] [Related]
16. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.
Hao Y; Numata K; Ishii T; Fukuda H; Maeda S; Nakano M; Tanaka K
World J Gastroenterol; 2017 May; 23(17):3111-3121. PubMed ID: 28533668
[TBL] [Abstract] [Full Text] [Related]
17. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
Huang GH; Shan H; Li D; Zhou B; Pang PF
Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
[TBL] [Abstract] [Full Text] [Related]
18. The
Scarpa L; Buxbaum S; Kendler D; Fink K; Bektic J; Gruber L; Decristoforo C; Uprimny C; Lukas P; Horninger W; Virgolini I
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):788-800. PubMed ID: 28083690
[TBL] [Abstract] [Full Text] [Related]
19. Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis.
Park JO; Ryoo BY; Yen CJ; Kudo M; Yang L; Abada PB; Cheng R; Orlando M; Zhu AX; Okusaka T
Oncotarget; 2016 Nov; 7(46):75482-75491. PubMed ID: 27776351
[TBL] [Abstract] [Full Text] [Related]
20. Quantitative proteome analysis reveals the correlation between endocytosis-associated proteins and hepatocellular carcinoma dedifferentiation.
Naboulsi W; Bracht T; Megger DA; Reis H; Ahrens M; Turewicz M; Eisenacher M; Tautges S; Canbay AE; Meyer HE; Weber F; Baba HA; Sitek B
Biochim Biophys Acta; 2016 Nov; 1864(11):1579-85. PubMed ID: 27519163
[TBL] [Abstract] [Full Text] [Related]
[Next]
